Fever and Neutropenia in a Child Without a Port
A 6-year-old with newly diagnosed precursor B-cell acute lymphoblastic leukemia completed induction chemotherapy 9 days ago and has no central venous catheter. She presents at 22:00 to a community hospital where you are the on-call pediatric hospitalist. Temperature is 38.6 C orally, heart rate 132, blood pressure 88/54, respirations 26, SpO2 97% on room air. She is tired but conversant, with dry mucous membranes and no focal findings on exam. The last absolute neutrophil count 3 days ago was 400/microliter. The hospital has no pediatric intensive care unit; transfer to a tertiary center is a 90-minute ground transport, and the local ED has one pediatric-trained nurse on nights. Blood cultures have just been drawn from a peripheral site. The pharmacy stocks ceftriaxone, piperacillin-tazobactam, and gentamicin, but not cefepime.
1. What is your immediate antibiotic and disposition decision, and what is the reasoning that drives it?
Read the worked answer
This is febrile neutropenia, an oncologic emergency where the time to appropriate empiric antibiotics is the outcome-critical variable. Empiric coverage must target Pseudomonas aeruginosa, so ceftriaxone alone is inadequate. Of the stocked options, piperacillin-tazobactam provides antipseudomonal beta-lactam coverage and is the best available choice; give it now, within roughly 60 minutes, rather than waiting for transport or for a cefepime shipment. Add gentamicin only if you suspect a resistant organism or hemodynamic instability; routine double coverage is not required for a stable patient.
Disposition is the harder judgment. She is currently hemodynamically borderline (tachycardia, borderline hypotension, dry mucous membranes) and 90 minutes from a pediatric ICU. The rule that governs is: never let logistics delay antibiotics, and never keep a neutropenic child in a facility that cannot rescue her if she decompensates. The correct sequence is to give the first dose of piperacillin-tazobactam locally, begin fluid resuscitation, and arrange urgent transfer to the tertiary center rather than admit locally for observation. Document the antibiotic administration time, obtain repeat vitals and lactate, and communicate directly with the accepting oncologist by phone.
2. The local pharmacist asks whether you can substitute ceftriaxone plus gentamicin because piperacillin-tazobactam requires more frequent dosing and nursing is short. How do you respond, and what is the pharmacologic reasoning?
Read the worked answer
Decline the substitution for empiric monotherapy. Ceftriaxone has poor and unreliable antipseudomonal activity and does not cover many resistant gram-negatives seen in neutropenic patients; pairing it with gentamicin does not fix the beta-lactam gap and adds nephrotoxicity and ototoxicity risk in a child who will receive multiple nephrotoxic agents during therapy. The standard of care is an antipseudomonal beta-lactam (cefepime, piperacillin-tazobactam, or meropenem) as empiric monotherapy.
The nursing constraint is real but is a workflow problem, not a reason to give inferior coverage. Practical solutions: give the first dose in the ED before transfer so the receiving center owns the ongoing dosing schedule; if the child stays briefly, use extended-infusion piperacillin-tazobactam per pharmacy protocol to reduce dosing frequency burden; escalate staffing through the charge nurse. The decision principle is that antimicrobial spectrum for a neutropenic child is not negotiable against convenience, whereas the dosing logistics are.